CLOs on the Move

Kemberton

www.kemberton.net

 
Kemberton is a leading provider of technology-enabled revenue cycle management services to hospitals for complex claims. We specialize in the management and collection of workers compensation, motor vehicle accident claims, veteran administration and the resolution of insurance denials for hospitals and physician practice groups. Kemberton helps accelerate collection times and maximize reimbursements for over 300 hospital clients across 35 states, resulting in over $1.5 billion dollars of incremental cash payments for our clients.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.kemberton.net
  • 501 Corporate Centre Suite 600
    Franklin, TN USA 37067
  • Phone: 877.540.0749

Executives

Name Title Contact Details
Greg Elliott
General Counsel Profile

Similar Companies

Champlain Valley Physicians Hospital

Champlain Valley Physicians Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Champlain Valley Physicians Hospital is based in Plattsburgh, NY. You can find more information on Champlain Valley Physicians Hospital at www.cvph.org

Eastern Maine Healthcare Systems

Eastern Maine Healthcare Systems (EMHS) is committed to delivering quality and cost-effective patient care despite the difficult healthcare environment that's challenging the nation and the residents of Maine.

Excelth Inc

Excelth Inc is a New Orleans, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BetterMynd

BetterMynd is an online therapy platform for college students that aims to increase accessibility to mental health services and reduce stigma surrounding mental distress in young adults.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.